v3.22.4
Fourth Quarter Financial Results (unaudited) (Tables)
12 Months Ended
Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]  
Schedule of fourth quarter financial results
quarter ended December 31 (in millions except per share data)2022
Net revenues$15,121 
Gross margin10,951 
Net earnings attributable to AbbVie Inc.
2,473 
Basic earnings per share attributable to AbbVie Inc.$1.39 
Diluted earnings per share attributable to AbbVie Inc.$1.38 
Cash dividends declared per common share$1.48